# Sterile Processing MVP closeout

**November 13 clarification and resumption:** the owner wanted to pause to assess
remaining work toward a workable client MVP, not declare that MVP complete.
The earlier completion wording below is historical and withdrawn as a client-MVP
status. Development has now resumed, starting with
[identity and access](IDENTITY-ACCESS.md). Prior test/owner evidence is retained;
it does not establish real-user or clinical acceptance. Optional report work
remains frozen while functional MVP gaps are addressed.

November 12, 2026 · `feature/sterile-processing-preview`

The owner requested a bounded MVP followed by a pause to assess the next phase.
The current MVP candidate is the standalone **local, fictional-data application
with manually recorded processing evidence**. It is not a clinical deployment.
Optional report features are now frozen. No further feature increment is needed
to finish this MVP review.

**Owner evidence received November 12, 2026; development paused.** The screenshot
shows the returned-package report loaded with nine linked records, 17 events,
Current holds and blocks (including the return block), and the Linked records
table. This establishes the core owner trace smoke result. Source links and the
expanded Recorded events section are below the captured viewport and are not
independently owner-confirmed. Their developer coverage remains recorded below.
The local MVP is closed for this bounded demonstration review; this is not full
U-TRACE-01, broader manual or clinical production acceptance. No additional owner
check or feature work is requested before the assessment.

## Scope and developer result

| Included in this MVP | Closeout evidence |
| --- | --- |
| Instrument/type records, receiving, cleaning, inspection and holds | Existing domain/service checks plus the connected normal-command journey below |
| Tray composition, assembly, packaging and labels | Existing scoped checks; connected journey rejects assembly before inspection and then completes packaging |
| Recorded cycle results and reviewer decisions | Passed cycle, operator review denial, reviewer hold/release, failed/aborted release denial and storage gates |
| Storage, issue, complete return and fresh reprocessing | Connected issue/return/disposition journey; old release facts stay historical while current restrictions remain |
| Recall recovery and quarantine | Connected recall, issue denial, recovery, quarantine and persisted block after case closure/restart |
| Durable local SQLite records, role/scope controls and history | Restart assertions, read-only auditor access, existing concurrency/idempotency/audit-rollback/isolation suites |
| Loaner/readmission, equipment, maintenance, consumable stock/counts and reports | Existing feature-specific automated checks and owner evidence in the testing register; no claim that every exception has owner acceptance |
| Reports hub, filters, presets, CSV and browser print/PDF | Existing web/service checks and recorded owner checks; latest additions stop here |

**Developer closeout passed:** 228 domain tests, 157 HTTP/SQLite tests and
87 web tests (472 total), plus four preview launcher-command tests. The web
production build passed. Its existing large-chunk warning remains a performance
backlog item, not a failed build or a measured production-scale result.

The two new durable tests in
`services/sterile-processing/test/mvp-workflow.test.mjs` start with fresh isolated
SQLite stores and use normal public commands, without example-creation helpers:

1. Receive → failed cleaning/retry → passed cleaning → inspection → assembly →
   package → passed cycle → reviewer hold/release → store/issue → complete used
   return → reviewer reprocess → linked fresh receipt → restart → trace/auditor
   verification. Duplicate receipt retry and premature/unauthorized actions are
   checked along the way.
2. Failed and aborted cycles cannot be released/stored. A separately released
   package is recalled, recovered and quarantined; issue stays blocked after
   closure and restart.

A developer Chromium check used the same first journey's saved records after
restart. It opened **Trace latest returned package**, verified linked return and
processing records/current blocks, downloaded CSV and checked that an unknown
exact code clears the old report. No page errors occurred. The connected journey
was exercised through HTTP; this was a browser trace smoke check, not an assertion
that every workflow form received a fresh combined manual walkthrough.

No application behavior changed in this closeout. Only regression tests and
readiness documentation were added. Existing records were not reset or migrated.

## One remaining owner check, then pause

**U-MVP-01 core smoke confirmed; remaining visual detail deferred:** In the existing local
preview, enter as Demo operator → **Traceability and reports** →
**Trace latest returned package**. Expect a returned package with linked workflow
records, **Current holds and blocks**, **Source links** and **Recorded events**.
See [the trace walkthrough](TRACEABILITY.md). This reads existing records; no
stock, package or workflow action is requested. No new UI build is required for
this check.

If no returned package is available, report that result rather than creating a
new demonstration batch or assuming a pass. A reproducible failure on an existing
supported journey is an MVP blocker to fix before closure.

**Original stop condition:** developer checks above pass, the owner confirms U-MVP-01,
and there is no unresolved blocker in this supported local journey. Then mark
the local demonstration MVP accepted and pause development. A response of “p”
alone is not acceptance. No new feature, migration, integration or production
release follows automatically. Assess the next phase separately with the owner.

Closeout disposition: the owner's screenshot satisfies the core supported-path
smoke check. Preserve the unseen lower-section checks as deferred evidence rather
than claiming they passed or extending development. Pause now as requested.

## Explicitly deferred assessment backlog

These are preserved, not silently accepted or required to expand this local MVP:

- **Clinical production identity and permissions:** verified people, competency,
  authentication and the independent-inspector/no-self-inspection rule
  [RSP-ISS-001](ISSUES.md). That rule remains parked at the owner's request and
  must be resolved before clinical production acceptance.
- **Operational and clinical readiness:** approved local procedures and evidence,
  exception/correction policies, physical recovery and reconciliation, real
  scanner/label/equipment verification, representative workload and staff UAT.
- **Production persistence and operations:** production adapter/migrations,
  deployment/security review, backup/restore and downtime drills, monitoring,
  capacity/performance and support ownership. SQLite restart tests do not prove
  disaster recovery or clinical continuity.
- **Known workflow boundaries:** remaining final-decision corrections,
  return/repair/disposal/clearance and cross-facility policies documented in
  [ISSUES.md](ISSUES.md). Implemented preview paths do not resolve every exception.
- **Optional enhancements:** purchasing, notifications, shared/scheduled presets,
  report polish, supplier identity/aggregation and Asset Management reuse. No
  automatic orders or notifications are implied by current stock suggestions.
- **Outstanding owner/manual evidence:** original U-LOANER-01 and all other
  unconfirmed checks remain in [TESTING-REGISTER.md](TESTING-REGISTER.md). They are
  not relabeled passed by this closeout. U-MVP-01 is the only owner check requested
  now; broader production/manual acceptance is deferred to the assessment.

The next assessment should choose the intended deployment and users first:
continue local demonstration, prepare a nonclinical pilot, or fund clinical
production readiness. Estimate that agreed scope after the pause; there is no
evidence-based completion percentage or calendar promise for clinical production.
